Advertisement

Current Trends in Epidemiology and Antimicrobial Resistance in Neonatal Sepsis

  • S. Chavez-Bueno
  • R. J. McCullohEmail author
Part of the Annual Update in Intensive Care and Emergency Medicine book series (AUICEM)

Introduction

Invasive infections are the cause of approximately 25% of deaths in newborns worldwide. In 2015, 336,300 neonatal deaths globally were attributed to sepsis and other neonatal infections [1]. Rates of neonatal sepsis are highest in African countries and lowest in North American and developed European countries. In addition to the different incidence of neonatal invasive disease, the pathogens causing neonatal sepsis and their antibiotic resistance patterns also vary in different regions of the world. This manuscript focuses on the epidemiological characteristics of sepsis in infants younger than 30 days of age in the developed world, and on recent antibiotic resistance trends observed in the pathogens that cause neonatal sepsis in the USA.

Rates of sepsis in newborns are inversely related to gestational age. Neonates rely on innate immune responses as the first line of defense against infections. These mechanisms are impaired in preterm newborns compared to term infants....

References

  1. 1.
    GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459–1544CrossRefGoogle Scholar
  2. 2.
    Weston EJ, Pondo T, Lewis MM et al (2011) The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J 30:937–941CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Stoll BJ, Hansen NI, Sanchez PJ et al (2011) Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 127:817–826CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Schrag SJ, Farley MM, Petit S et al (2016) Epidemiology of Invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics 138:e20162013CrossRefGoogle Scholar
  5. 5.
    Le Doare K, Heath PT (2013) An overview of global GBS epidemiology. Vaccine 31(Suppl 4):D7–D12CrossRefGoogle Scholar
  6. 6.
    Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) (2010) Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 59:1–36PubMedGoogle Scholar
  7. 7.
    Edmond KM, Kortsalioudaki C, Scott S et al (2012) Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379:547–556CrossRefGoogle Scholar
  8. 8.
    CDC: Centers for Disease Control and Prevention (2015) Active bacterial core surveillance report, emerging infections program network, group B streptococcus, 2015. Available at www.cdc.gov/abcs/reports-findings/survreports/gbs15.pdf. Accessed 27 December 2017Google Scholar
  9. 9.
    Moore MR, Schrag SJ, Schuchat A (2003) Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 3:201–213CrossRefGoogle Scholar
  10. 10.
    Stoll BJ, Hansen NI, Higgins RD et al (2005) Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J 24:635–639CrossRefGoogle Scholar
  11. 11.
    Greenhow TL, Hung YY, Herz AM (2012) Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 129:e590–e596CrossRefGoogle Scholar
  12. 12.
    Stoll BJ, Hansen N, Fanaroff AA et al (2002) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285–291CrossRefGoogle Scholar
  13. 13.
    Greenberg RG, Kandefer S, Do BT et al (2017) Late-onset sepsis in extremely premature infants: 2000–2011. Pediatr Infect Dis J 36:774–779CrossRefGoogle Scholar
  14. 14.
    Jordan HT, Farley MM, Craig A et al (2008) Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 27:1057–1064CrossRefGoogle Scholar
  15. 15.
    Biondi E, Evans R, Mischler M et al (2013) Epidemiology of bacteremia in febrile infants in the United States. Pediatrics 132:990–996CrossRefGoogle Scholar
  16. 16.
    Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG (2008) Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 121:689–696CrossRefGoogle Scholar
  17. 17.
    Cohen-Wolkowiez M, Moran C, Benjamin DK et al (2009) Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 28:1052–1056CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Phares CR, Lynfield R, Farley MM et al (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 299:2056–2065CrossRefGoogle Scholar
  19. 19.
    Shakir SM, Goldbeck JM, Robison D, Eckerd AM, Chavez-Bueno S (2014) Genotypic and phenotypic characterization of invasive neonatal Escherichia coli clinical isolates. Am J Perinatol 31:975–982CrossRefGoogle Scholar
  20. 20.
    Bergin SP, Thaden JT, Ericson JE et al (2015) Neonatal Escherichia coli bloodstream infections: clinical outcomes and impact of initial antibiotic therapy. Pediatr Infect Dis J 34:933–936CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Shane AL, Stoll BJ (2013) Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 30:131–141CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Camacho-Gonzalez A, Spearman PW, Stoll BJ (2013) Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am 60:367–389CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Kelly MS, Benjamin DK Jr., Smith PB (2015) The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol 42:105–117 (viii–ix)CrossRefGoogle Scholar
  24. 24.
    Singhi S, Rao DS, Chakrabarti A (2008) Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 9:91–95CrossRefGoogle Scholar
  25. 25.
    Garzillo C, Bagattini M, Bogdanovic L et al (2017) Risk factors for Candida parapsilosis bloodstream infection in a neonatal intensive care unit: a case-control study. Ital J Pediatr 43:10CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345:1660–1666CrossRefGoogle Scholar
  27. 27.
    Kaufman DA, Coggins SA, Zanelli SA, Weitkamp JH (2017) Congenital cutaneous candidiasis: prompt systemic treatment is associated with improved outcomes in neonates. Clin Infect Dis 64:1387–1395CrossRefGoogle Scholar
  28. 28.
    Calley JL, Warris A (2017) Recognition and diagnosis of invasive fungal infections in neonates. J Infect 74(Suppl 1):S108–S113CrossRefGoogle Scholar
  29. 29.
    Cuenca-Estrella M, Verweij PE, Arendrup MC et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl 7):9–18CrossRefGoogle Scholar
  30. 30.
    Benjamin DK Jr., Stoll BJ, Fanaroff AA et al (2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117:84–92CrossRefGoogle Scholar
  31. 31.
    Cioffredi LA, Jhaveri R (2016) Evaluation and management of febrile children: a review. JAMA Pediatr 170:794–800CrossRefGoogle Scholar
  32. 32.
    Cerone JB, Santos RP, Tristram D et al (2017) Incidence of respiratory viral infection in infants with respiratory symptoms evaluated for late-onset sepsis. J Perinatol 37:922–926CrossRefGoogle Scholar
  33. 33.
    van Well GTJ, Daalderop LA, Wolfs T, Kramer BW (2017) Human perinatal immunity in physiological conditions and during infection. Mol Cell Pediatr 4:4CrossRefPubMedCentralGoogle Scholar
  34. 34.
    Zhu K, Yang J, Luo K et al (2015) TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection. Plos Pathog 11:e1004613CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Abzug MJ, Michaels MG, Wald E et al (2016) A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with Enterovirus sepsis. J Pediatric Infect Dis Soc 5:53–62CrossRefGoogle Scholar
  36. 36.
    Torres-Torres S, Myers AL, Klatte JM et al (2015) First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. Pediatr Infect Dis J 34:52–54CrossRefGoogle Scholar
  37. 37.
    Kimberlin DW, Baley J, Committee on Infectious Diseases, Committee on Fetus and Newborn (2013) Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 131:383–386CrossRefGoogle Scholar
  38. 38.
    James SH, Kimberlin DW (2015) Neonatal herpes simplex virus infection. Infect Dis Clin North Am 29:391–400CrossRefGoogle Scholar
  39. 39.
    Smith CK, Arvin AM (2009) Varicella in the fetus and newborn. Semin Fetal Neonatal Med 14:209–217CrossRefGoogle Scholar
  40. 40.
    Dagan R, Powell KR, Hall CB, Menegus MA (1985) Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr 107:855–860CrossRefPubMedCentralGoogle Scholar
  41. 41.
    Rasmussen SA, Jamieson DJ, Uyeki TM (2012) Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 207(3 Suppl):S3–S8CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Nunes MC, Madhi SA (2017) Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: a systematic review and meta-analysis. Hum Vaccin Immunother 14:1–9Google Scholar
  43. 43.
    Chen VL, Avci FY, Kasper DL (2013) A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine 31(Suppl 4):D13–D19CrossRefPubMedCentralGoogle Scholar
  44. 44.
    Manzoni P, Stolfi I, Pugni L et al (2007) A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356:2483–2495CrossRefGoogle Scholar
  45. 45.
    Lee J, Kim HS, Shin SH et al (2016) Efficacy and safety of fluconazole prophylaxis in extremely low birth weight infants: multicenter pre-post cohort study. BMC Pediatr 16:67CrossRefPubMedCentralGoogle Scholar
  46. 46.
    Fanaroff AA, Stoll BJ, Wright LL et al (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196:147.e1–147.e8CrossRefGoogle Scholar
  47. 47.
    Edwards MS, Baker CJ (2008) Bacterial infections in the neonate. In: Long SS, Pickering LK, Prober CG (eds) Principles and Practice of Pediatric Infectious Diseases, 3rd edn. Churchill Livingstone, Philadelphia, p 537Google Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Children’s Mercy Kansas CityKansas CityUSA
  2. 2.University of MissouriKansas CityUSA
  3. 3.University of Kansas Medical CenterKansas CityUSA

Personalised recommendations